Risk factors for completed suicide among people who use drugs: A scoping review protocol [version 3; peer review: 1 approved, 2 approved with reservations]

Background: Research over the past several decades has shown an increased risk for completed suicide among people who use drugs (PWUD). However, no study to date has attempted to summarise the available literature on the variety of risk factors associated with this increased risk. This paper present...

Full description

Bibliographic Details
Main Authors: Lisa Murphy, Suzi Lyons, Michael O'Sullivan, Ena Lynn
Format: Article
Language:English
Published: F1000 Research Ltd 2021-05-01
Series:HRB Open Research
Online Access:https://hrbopenresearch.org/articles/3-45/v3
id doaj-c7b8ba7c85034ca6b59f4387fa060544
record_format Article
spelling doaj-c7b8ba7c85034ca6b59f4387fa0605442021-05-24T09:59:39ZengF1000 Research LtdHRB Open Research2515-48262021-05-01310.12688/hrbopenres.13098.314400Risk factors for completed suicide among people who use drugs: A scoping review protocol [version 3; peer review: 1 approved, 2 approved with reservations]Lisa Murphy0Suzi Lyons1Michael O'Sullivan2Ena Lynn3Health Research Board, Dublin 2, IrelandHealth Research Board, Dublin 2, IrelandHealth Research Board, Dublin 2, IrelandHealth Research Board, Dublin 2, IrelandBackground: Research over the past several decades has shown an increased risk for completed suicide among people who use drugs (PWUD). However, no study to date has attempted to summarise the available literature on the variety of risk factors associated with this increased risk. This paper presents a protocol for a scoping review that aims to systematically map and synthesise the extent and nature of published, unpublished and grey literature related to risk factors for suicide among PWUD. Methods: The following six-stage methodological framework for scoping reviews proposed by Arksey and O’Malley with enhancements by Levac and colleagues will be used: (1) identifying the research question, (2) identifying relevant studies, (3) study selection, (4) charting/mapping the data, (5) collating, summarising and reporting results and (6) expert consultation. The review will be conducted and reported in accordance with the PRISMA Extension for Scoping Reviews (PRISMA-ScR). Key inclusion and exclusion criteria will be developed to guide literature screening and data charting. Three reviewers will conduct the initial screening of published, unpublished and grey literature. Identified risk factors will be collated, summarised and categorised iteratively by two independent reviewers. Stakeholder consultation will occur with experts from a national steering committee, a national advisory group, a national suicide prevention centre and a European drug monitoring centre. Conclusion: Collating and thematically categorising the various risk factors for suicide among this high-risk group will hold important implications for future research, policy and practice. The research will be disseminated through publication in a peer-reviewed academic journal and a conference presentation, and by sharing the findings with key stakeholders working within research, policy-making and professional practice contexts.https://hrbopenresearch.org/articles/3-45/v3
collection DOAJ
language English
format Article
sources DOAJ
author Lisa Murphy
Suzi Lyons
Michael O'Sullivan
Ena Lynn
spellingShingle Lisa Murphy
Suzi Lyons
Michael O'Sullivan
Ena Lynn
Risk factors for completed suicide among people who use drugs: A scoping review protocol [version 3; peer review: 1 approved, 2 approved with reservations]
HRB Open Research
author_facet Lisa Murphy
Suzi Lyons
Michael O'Sullivan
Ena Lynn
author_sort Lisa Murphy
title Risk factors for completed suicide among people who use drugs: A scoping review protocol [version 3; peer review: 1 approved, 2 approved with reservations]
title_short Risk factors for completed suicide among people who use drugs: A scoping review protocol [version 3; peer review: 1 approved, 2 approved with reservations]
title_full Risk factors for completed suicide among people who use drugs: A scoping review protocol [version 3; peer review: 1 approved, 2 approved with reservations]
title_fullStr Risk factors for completed suicide among people who use drugs: A scoping review protocol [version 3; peer review: 1 approved, 2 approved with reservations]
title_full_unstemmed Risk factors for completed suicide among people who use drugs: A scoping review protocol [version 3; peer review: 1 approved, 2 approved with reservations]
title_sort risk factors for completed suicide among people who use drugs: a scoping review protocol [version 3; peer review: 1 approved, 2 approved with reservations]
publisher F1000 Research Ltd
series HRB Open Research
issn 2515-4826
publishDate 2021-05-01
description Background: Research over the past several decades has shown an increased risk for completed suicide among people who use drugs (PWUD). However, no study to date has attempted to summarise the available literature on the variety of risk factors associated with this increased risk. This paper presents a protocol for a scoping review that aims to systematically map and synthesise the extent and nature of published, unpublished and grey literature related to risk factors for suicide among PWUD. Methods: The following six-stage methodological framework for scoping reviews proposed by Arksey and O’Malley with enhancements by Levac and colleagues will be used: (1) identifying the research question, (2) identifying relevant studies, (3) study selection, (4) charting/mapping the data, (5) collating, summarising and reporting results and (6) expert consultation. The review will be conducted and reported in accordance with the PRISMA Extension for Scoping Reviews (PRISMA-ScR). Key inclusion and exclusion criteria will be developed to guide literature screening and data charting. Three reviewers will conduct the initial screening of published, unpublished and grey literature. Identified risk factors will be collated, summarised and categorised iteratively by two independent reviewers. Stakeholder consultation will occur with experts from a national steering committee, a national advisory group, a national suicide prevention centre and a European drug monitoring centre. Conclusion: Collating and thematically categorising the various risk factors for suicide among this high-risk group will hold important implications for future research, policy and practice. The research will be disseminated through publication in a peer-reviewed academic journal and a conference presentation, and by sharing the findings with key stakeholders working within research, policy-making and professional practice contexts.
url https://hrbopenresearch.org/articles/3-45/v3
work_keys_str_mv AT lisamurphy riskfactorsforcompletedsuicideamongpeoplewhousedrugsascopingreviewprotocolversion3peerreview1approved2approvedwithreservations
AT suzilyons riskfactorsforcompletedsuicideamongpeoplewhousedrugsascopingreviewprotocolversion3peerreview1approved2approvedwithreservations
AT michaelosullivan riskfactorsforcompletedsuicideamongpeoplewhousedrugsascopingreviewprotocolversion3peerreview1approved2approvedwithreservations
AT enalynn riskfactorsforcompletedsuicideamongpeoplewhousedrugsascopingreviewprotocolversion3peerreview1approved2approvedwithreservations
_version_ 1721428710742032384